Palvella Therapeutics (PVLA) Return on Equity [ROE] (2014 - 2026)
Palvella Therapeutics' Return on Equity [ROE] came in at -27.47% for Q2 2026, up 27.45 percentage points from -54.92% a year earlier and up 10.41 percentage points from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Palvella Therapeutics' Return on Equity [ROE] was -92.10%.
- Return on Equity [ROE] carries a five-year change of -1.71 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -111.85% in FY2021 (-21.47 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q2 2020.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2026 (a gain of 27.45 percentage points), and the weakest in Q3 2021 (a drop of 56.56 percentage points).
- Business Quant data shows PVLA's Return on Equity [ROE] at -37.88% (Q1 2026), -125.15% (Q4 2025) and -76.22% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Palvella Therapeutics | 2.47 Bn | 2.23 Bn | - | -36.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -36.18% |
| Jun 30, 2026 | -27.38% |
| Mar 31, 2026 | -37.80% |
| Dec 31, 2025 | -124.91% |
| Sep 30, 2025 | -74.64% |
| Jun 30, 2025 | -54.38% |
| Mar 31, 2025 | -38.74% |
| Sep 30, 2023 | -81.47% |
| Jun 30, 2023 | -99.39% |
| Sep 30, 2022 | -86.85% |
| Jun 30, 2022 | -84.07% |
| Mar 31, 2022 | -88.11% |
| Dec 31, 2021 | -85.30% |
| Sep 30, 2021 | -97.85% |
| Jun 30, 2021 | -110.77% |
| Mar 31, 2021 | -105.06% |
| Dec 31, 2020 | -95.10% |
| Sep 30, 2020 | -52.42% |
| Jun 30, 2020 | -21.28% |
| Mar 31, 2020 | -35.37% |
API Access
Palvella Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();